Trades on 1 secondary market

Roivant Sciences

Roivant Sciences (Nasdaq: ROIV) is a holding company that builds focused subsidiary biotech and health-tech operating units called "Vants." Founded by Vivek Ramaswamy in 2014 and now led by CEO Matt Gline, Roivant has launched companies across immunology (Immunovant, Priovant, Covant, PsiThera), pul

developing 45.0 / 100 4 APIs View provider profile →

Biotech Pharmaceutical Drug Development Clinical Trials Health Data Tokenization

Roivant Sciences is an API provider whose private shares are listed on 1 secondary market: Augment.

Roivant Sciences publishes 4 APIs indexed on the APIs.io network.

Where It Trades

A Augment View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.